These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17852846)

  • 1. Renal function and cognitive impairment in patients with liver cirrhosis.
    Kalaitzakis E; Björnsson E
    Scand J Gastroenterol; 2007 Oct; 42(10):1238-44. PubMed ID: 17852846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.
    Kalaitzakis E; Olsson R; Henfridsson P; Hugosson I; Bengtsson M; Jalan R; Björnsson E
    Liver Int; 2007 Nov; 27(9):1194-201. PubMed ID: 17919230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis.
    Pirlich M; Selberg O; Böker K; Schwarze M; Müller MJ
    Hepatology; 1996 Dec; 24(6):1422-7. PubMed ID: 8938174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation.
    Senzolo M; Amodio P; D'Aloiso MC; Fagiuoli S; Del Piccolo F; Canova D; Masier A; Bassanello M; Zanus G; Burra P
    Transplant Proc; 2005 Mar; 37(2):1104-7. PubMed ID: 15848636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
    Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M
    Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing renal function in cirrhotic patients: problems and pitfalls.
    Sherman DS; Fish DN; Teitelbaum I
    Am J Kidney Dis; 2003 Feb; 41(2):269-78. PubMed ID: 12552488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience.
    Dehghani SM; Derakhshan A; Taghavi SA; Gholami S; Jalaeian H; Malek-Hosseini SA
    Exp Clin Transplant; 2008 Mar; 6(1):25-9. PubMed ID: 18405241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests.
    Amodio P; Del Piccolo F; Marchetti P; Angeli P; Iemmolo R; Caregaro L; Merkel C; Gerunda G; Gatta A
    Hepatology; 1999 Jun; 29(6):1662-7. PubMed ID: 10347105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
    Compañy L; Zapater P; Pérez-Mateo M; Jover R
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):519-25. PubMed ID: 20010298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume.
    Garcia-Martinez R; Rovira A; Alonso J; Jacas C; Simón-Talero M; Chavarria L; Vargas V; Córdoba J
    Liver Transpl; 2011 Jan; 17(1):38-46. PubMed ID: 21254343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.
    Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O
    J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis.
    Jover R; Compañy L; Gutiérrez A; Zapater P; Pérez-Serra J; Girona E; Aparicio JR; Pérez-Mateo M
    Am J Gastroenterol; 2003 Jul; 98(7):1599-604. PubMed ID: 12873585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual attention in cirrhotic patients: a study on covert visual attention orienting.
    Amodio P; Marchetti P; Del Piccolo F; Campo G; Rizzo C; Iemmolo RM; Gerunda G; Caregaro L; Merkel C; Gatta A
    Hepatology; 1998 Jun; 27(6):1517-23. PubMed ID: 9620321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
    Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
    J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyponatremia of cirrhosis: role of vasopressin and decreased 'effective' plasma volume.
    Akriviadis EA; Ervin MG; Cominelli F; Fisher DA; Reynolds TB
    Scand J Gastroenterol; 1997 Aug; 32(8):829-34. PubMed ID: 9282977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study.
    Oppong KN; Al-Mardini H; Thick M; Record CO
    Hepatology; 1997 Oct; 26(4):870-6. PubMed ID: 9328307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
    Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis.
    Kalaitzakis E; Josefsson A; Castedal M; Henfridsson P; Bengtsson M; Andersson B; Björnsson E
    Scand J Gastroenterol; 2013 May; 48(5):577-84. PubMed ID: 23452072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P300 latency for the diagnosis of minimal hepatic encephalopathy: evidence that spectral EEG analysis and psychometric tests are enough.
    Amodio P; Valenti P; Del Piccolo F; Pellegrini A; Schiff S; Angeli P; Poci C; Mapelli D; Iannizzi P; Gatta A
    Dig Liver Dis; 2005 Nov; 37(11):861-8. PubMed ID: 16183341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.